Captor Therapeutics Spolka Akcyjna reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported net loss was PLN 59.1 million compared to PLN 29.38 million a year ago. Basic loss per share from continuing operations was PLN 13.92 compared to PLN 7.05 a year ago.